Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19 https://t.co/bVjyQtSTjp https://t.co/8336Ck0XDJ
RT @Prison_Health: Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19 https://t.co/bVjyQtBhUP https://t.co/Y7CY47U…
Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19 https://t.co/bVjyQtBhUP https://t.co/Y7CY47Uh9F
RT @CDUHR_NYC: Check out the latest article from CDUHR investigators @UtshaKhatriMD, Babak Tofighi, and @NoaKrawczyk - Buprenorphine Teleh…
RT @CDUHR_NYC: Check out the latest article from CDUHR investigators @UtshaKhatriMD, Babak Tofighi, and @NoaKrawczyk - Buprenorphine Teleh…
Check out the latest article from CDUHR investigators @UtshaKhatriMD, Babak Tofighi, and @NoaKrawczyk - Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19 https://t.co/xSJq253oZH https://t.co/iFbS8tssDq
Who else requires a phone? !!
RT @DrMichelleLin: I've treated more overdose than #COVID my last 3 shifts & I'm certain overdose are at a record Very encouraging work de…
RT @opioidsCOBRE: “Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19” by @LizSamuels @UtshaKhatriMD @HannahSnyder…
RT @opioidsCOBRE: “Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19” by @LizSamuels @UtshaKhatriMD @HannahSnyder…
RT @DrMichelleLin: I've treated more overdose than #COVID my last 3 shifts & I'm certain overdose are at a record Very encouraging work de…
RT @DrMichelleLin: I've treated more overdose than #COVID my last 3 shifts & I'm certain overdose are at a record Very encouraging work de…
I've treated more overdose than #COVID my last 3 shifts & I'm certain overdose are at a record Very encouraging work demonstrating uptake of tele-buprenorphine: 85% of patients were initiating treatment AND 83% returned within 30 days strong work @
RT @opioidsCOBRE: “Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19” by @LizSamuels @UtshaKhatriMD @HannahSnyder…
RT @opioidsCOBRE: “Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19” by @LizSamuels @UtshaKhatriMD @HannahSnyder…
RT @opioidsCOBRE: “Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19” by @LizSamuels @UtshaKhatriMD @HannahSnyder…
“Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19” by @LizSamuels @UtshaKhatriMD @HannahSnyderMD et. al. via @JournalGIM #RICobre https://t.co/KxMFJtBKQJ
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
RT @KatieWitkiewitz: The bright spots in this pandemic are few and far between. Making life saving medications more accessible is one of th…
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
RT @opioidsCOBRE: 🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiat…
🚨New pub alert!🚨 @LizSamuels @UtshaKhatriMD @HannahSnyderMD et al. found that buprenorphine telehealth treatment initiation and follow-up during COVID-19 was feasible & presents an evidence-based approach to preventing overdose. #RICobre https://t.c
RT @JournalGIM: Tele-buprenorphine is feasible and has high patient retention across different practice settings. @LizSamuels https://t.co/…
RT @JournalGIM: Tele-buprenorphine is feasible and has high patient retention across different practice settings. @LizSamuels https://t.co/…
RT @JournalGIM: Tele-buprenorphine is feasible and has high patient retention across different practice settings. @LizSamuels https://t.co/…
Tele-buprenorphine is feasible and has high patient retention across different practice settings. @LizSamuels https://t.co/O1pXjM3Ofk https://t.co/l4LSLUuGIc
RT @LizSamuels: @JSchuurMD Thank you! Well timed with our new paper in @JournalGIM showing high treatment follow up! 👇🏼
@JSchuurMD Thank you! Well timed with our new paper in @JournalGIM showing high treatment follow up! 👇🏼
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @DrSuziNielsen: One of the positive things to come out of the past 2yrs is that we found ways to make OUD treatment more accessible. Let…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @KatieWitkiewitz: The bright spots in this pandemic are few and far between. Making life saving medications more accessible is one of th…
RT @DrSuziNielsen: One of the positive things to come out of the past 2yrs is that we found ways to make OUD treatment more accessible. Let…
RT @DrSuziNielsen: One of the positive things to come out of the past 2yrs is that we found ways to make OUD treatment more accessible. Let…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @DrSuziNielsen: One of the positive things to come out of the past 2yrs is that we found ways to make OUD treatment more accessible. Let…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @DrAyanaJordan: This is huge!!!! Let’s maximize tele bup to get people the care they deserve
YES!! Let’s make it happen! Let’s remove the liquid handcuff now!! #bup
This is huge!!!! Let’s maximize tele bup to get people the care they deserve
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @veruka2: YES! MORE OF THIS KIND OF FLEXIBLE, ACCESSIBLE HEALTH CARE SERVICE PLEASE! Telehealth cannot be the end all be all. It won't s…
Great application of telehealth! @DrAndreaWeber Is this an option in Iowa?
RT @veruka2: YES! MORE OF THIS KIND OF FLEXIBLE, ACCESSIBLE HEALTH CARE SERVICE PLEASE! Telehealth cannot be the end all be all. It won't s…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @DrSuziNielsen: One of the positive things to come out of the past 2yrs is that we found ways to make OUD treatment more accessible. Let…
RT @KatieWitkiewitz: The bright spots in this pandemic are few and far between. Making life saving medications more accessible is one of th…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
One of the positive things to come out of the past 2yrs is that we found ways to make OUD treatment more accessible. Let's try this in Australia! @MonashAddiction @TurningPointAU @SArunogiri @dan_lubman
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
Fantastic result for a patient population that has challenging access to care
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
This is awesome
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @veruka2: YES! MORE OF THIS KIND OF FLEXIBLE, ACCESSIBLE HEALTH CARE SERVICE PLEASE! Telehealth cannot be the end all be all. It won't s…
YES! MORE OF THIS KIND OF FLEXIBLE, ACCESSIBLE HEALTH CARE SERVICE PLEASE! Telehealth cannot be the end all be all. It won't serve every single person well. We need more than this for low barrier MOUD. But this is a huge piece for so many people seeking su
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @PennCMH: Important paper describing potential for telehealth to increase access to buprenorphine, a life-saving evidence-based medicati…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
Important paper describing potential for telehealth to increase access to buprenorphine, a life-saving evidence-based medication for OUD. This strategy can be beneficial for rapid scaling in existing clinics, continued care, and facilitating access!
While I'm retweeting about OUD, check out this awesome study of tele-bupe for OUD treatment initiation.
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
from JGIM author @UtshaKhatriMD
RT @KatieWitkiewitz: The bright spots in this pandemic are few and far between. Making life saving medications more accessible is one of th…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @KatieWitkiewitz: The bright spots in this pandemic are few and far between. Making life saving medications more accessible is one of th…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
RT @UtshaKhatriMD: 🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continu…
The bright spots in this pandemic are few and far between. Making life saving medications more accessible is one of the few bright spots. Thank you for this important work.
🚨📰 New Paper Alert! @JournalGIM Tele-buprenorphine is feasible for OUD treatment initiation AND 83% of patients continued care at 30 days in our multi-site, retrospective cohort study. Over half of the visits used audio-only telehealth. https://t.co/WJSh